Last updated 2026-08-06
- Raised $22M Seed round led by Bill & Melinda Gates Foundation, Aug 2022
- Raised $3.9M grant led by Bill & Melinda Gates Foundation, Jun 2021
- Raised grant led by Innovate UK, Dec 2021
Total raised
$25.9M
Stage
—
Founded
2020
Headcount
—
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences
About
Eleven Therapeutics is a biotechnology company pioneering the next generation of RNA therapeutics. The company leverages artificial intelligence, massively parallel functional assays, and combinatorial chemistry to transform RNA drug development into a programmable process. They are developing novel modalities like SCSI-RNA™ (smart-combinatorial, small interfering RNA) and xRNA (extended-release mRNA) to address delivery, durability, and efficacy challenges in various diseases, with an initial focus on respiratory and cardiometabolic conditions. The company operates with collaborative hubs in Tel Aviv, Israel; Cambridge, UK; and Boston, U.S.
Funding history · 4 rounds · $25.9M total
2022-08
Seed
$22.0M
★ Bill & Melinda Gates FoundationNFX BioNFX CapitalEntrée CapitalKindred CapitalInnovate UK Smart GrantHarel Insurance & FinanceHarel Technology Investments
2021-12
Grant
Undisclosed
★ Innovate UK
2021-06
Grant
$3.9M
★ Bill & Melinda Gates FoundationInnovate UKInnovate UK Smart Grant
2020-08
Pre-Seed
Undisclosed
★ Entrée Capital
Q&A
- What is Eleven Therapeutics' primary focus?
- Eleven Therapeutics is a biotechnology company focused on pioneering the next generation of RNA therapeutics by combining AI, massively parallel functional assays, and combinatorial chemistry.
- When was Eleven Therapeutics founded?
- Eleven Therapeutics was founded in 2020.
- How much funding has Eleven Therapeutics raised in total?
- Eleven Therapeutics has raised a total of $22,000,000 USD.
- When did Eleven Therapeutics complete its Seed funding round and who were the lead investors?
- In August 2022, Eleven Therapeutics completed a Seed funding round of $22,000,000 USD. The Bill & Melinda Gates Foundation was a lead investor.
- Who are the co-founders of Eleven Therapeutics?
- The co-founders of Eleven Therapeutics are Yaniv Erlich (CEO), Shaul Ilan (COO), and Greg Hannon (Scientific Co-founder).
- Where are Eleven Therapeutics' collaborative hubs located?
- Eleven Therapeutics operates with collaborative hubs in Tel Aviv, Israel; Cambridge, UK; and Boston, U.S.
- What is Eleven Therapeutics' employee count as of August 2026?
- As of August 2026, Eleven Therapeutics has 30 employees.
- Who is the current CEO of Eleven Therapeutics?
- Adi Gilboa-Geffen was appointed CEO of Eleven Therapeutics in May 2023.
Team · 12
Yaniv Erlich
Founder · CEO and Co-founder
Shaul Ilan
Founder · COO and Co-founder
Greg Hannon
Founder · Scientific Co-founder
Adi Gilboa-Geffen
CEO
Iris Grossman
Chief Therapeutics Officer
Paloma H Giangrande
Chief Technology Officer
Ohad Yogev
UK Site Lead & Executive Director of Cellular Biology
Inês Martins Tomas
Scientist III
Laura Butler
Site Operations Manager
Anaïs Depaix
Associate Principal Scientist
André Xavier
Associate Scientist
Arun Tanpure
Senior Director of Nucleic Acid Chemistry
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | eleventx.com/ |
|---|
Identifiers & details
| Legal name | Eleven Therapeutics |
|---|---|
| Founded | 2020 |
Radar intelligence
Patents
| EPO | 10 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516183977 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-04-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 1 — other (1) |
| Registered address | דרך אבא הלל 16 רמת גן |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-04 | עדכון כתובת ו/או מען דיגיטלי |